Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123913622 | 12391362 | 2 | F | 20160831 | 20160520 | 20160906 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-038277 | BRISTOL MYERS SQUIBB | 86.00 | YR | M | Y | 42.40000 | KG | 20160906 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123913622 | 12391362 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | U | 202155 | ||||||||||
| 123913622 | 12391362 | 2 | SS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | 1.75 MG, UNK | U | 0 | 1.75 | MG | |||||||
| 123913622 | 12391362 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG | |||||||
| 123913622 | 12391362 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | 2.5 MG, UNK | U | 0 | 2.5 | MG | |||||||
| 123913622 | 12391362 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 123913622 | 12391362 | 6 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 25 MG, UNK | U | 0 | 25 | MG | |||||||
| 123913622 | 12391362 | 7 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | 2.5 MG, UNK | U | 0 | 2.5 | MG | |||||||
| 123913622 | 12391362 | 8 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 123913622 | 12391362 | 9 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | 1500 MG, UNK | U | 0 | 1500 | MG | |||||||
| 123913622 | 12391362 | 10 | C | SENNOSIDE /00571901/ | SENNOSIDES A AND B | 1 | Unknown | 12 MG, UNK | U | 0 | 12 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123913622 | 12391362 | 1 | Product used for unknown indication |
| 123913622 | 12391362 | 2 | Product used for unknown indication |
| 123913622 | 12391362 | 3 | Product used for unknown indication |
| 123913622 | 12391362 | 4 | Product used for unknown indication |
| 123913622 | 12391362 | 5 | Product used for unknown indication |
| 123913622 | 12391362 | 6 | Product used for unknown indication |
| 123913622 | 12391362 | 7 | Product used for unknown indication |
| 123913622 | 12391362 | 8 | Product used for unknown indication |
| 123913622 | 12391362 | 9 | Product used for unknown indication |
| 123913622 | 12391362 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123913622 | 12391362 | OT |
| 123913622 | 12391362 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123913622 | 12391362 | Cardiac failure chronic | |
| 123913622 | 12391362 | Contraindicated product administered | |
| 123913622 | 12391362 | Disseminated intravascular coagulation | |
| 123913622 | 12391362 | Haematochezia | |
| 123913622 | 12391362 | Jaundice |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |